Millennium Management LLC reduced its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 56.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 602,790 shares of the real estate investment trust's stock after selling 783,100 shares during the quarter. Millennium Management LLC owned about 0.25% of Sabra Health Care REIT worth $10,440,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Sabra Health Care REIT by 5.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,319,301 shares of the real estate investment trust's stock worth $22,850,000 after acquiring an additional 70,120 shares in the last quarter. Lazard Asset Management LLC raised its position in Sabra Health Care REIT by 44.2% in the fourth quarter. Lazard Asset Management LLC now owns 71,847 shares of the real estate investment trust's stock worth $1,244,000 after acquiring an additional 22,019 shares in the last quarter. Janus Henderson Group PLC raised its position in Sabra Health Care REIT by 23.1% in the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock worth $60,720,000 after acquiring an additional 657,950 shares in the last quarter. Jefferies Financial Group Inc. bought a new stake in Sabra Health Care REIT in the fourth quarter worth about $348,000. Finally, Graham Capital Management L.P. raised its position in Sabra Health Care REIT by 105.1% in the fourth quarter. Graham Capital Management L.P. now owns 200,651 shares of the real estate investment trust's stock worth $3,475,000 after acquiring an additional 102,812 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.
Sabra Health Care REIT Trading Up 0.1%
SBRA traded up $0.02 during trading on Thursday, reaching $17.42. The company had a trading volume of 371,155 shares, compared to its average volume of 2,379,670. The firm's 50-day simple moving average is $17.53 and its 200 day simple moving average is $17.36. The company has a market cap of $4.14 billion, a price-to-earnings ratio of 32.88, a PEG ratio of 1.97 and a beta of 0.88. Sabra Health Care REIT, Inc. has a 12-month low of $13.87 and a 12-month high of $20.03. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.01. The firm had revenue of $183.54 million for the quarter, compared to analysts' expectations of $180.23 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. Sabra Health Care REIT's revenue was up 10.1% on a year-over-year basis. During the same quarter last year, the business posted $0.35 EPS. Equities research analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.
Sabra Health Care REIT Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, May 30th. Investors of record on Friday, May 16th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a yield of 6.89%. Sabra Health Care REIT's dividend payout ratio is currently 203.39%.
Insider Buying and Selling at Sabra Health Care REIT
In other Sabra Health Care REIT news, Director Michael J. Foster sold 11,000 shares of Sabra Health Care REIT stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the transaction, the director now owns 64,725 shares of the company's stock, valued at $1,179,289.50. The trade was a 14.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 1.10% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have commented on the stock. Truist Financial boosted their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, March 18th. Scotiabank boosted their price target on shares of Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a research report on Monday, May 12th. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $19.50.
Check Out Our Latest Stock Report on Sabra Health Care REIT
Sabra Health Care REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also

Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.